Daniel Hägerstrand

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: LEUKEMIA. 2024;:1-14
The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia
Hagerstrand D; Oder B; Cortese D; Qu Y; Binzer-Panchal A; Osterholm C; Santos TDP; Rabbani L; Asl HF; Skaftason A; Ljungstrom V; Lundholm A; Koutroumani M; Haider Z; Jylha C; Mollstedt J; Mansouri L; Plevova K; Agathangelidis A; Scarfo L; Armand M; Muggen AF; Kay NE; Shanafelt T; Rossi D; Orre LM; Pospisilova S; Barylyuk K; Davi F; Vesterlund M; Langerak AW; Lehtio J; Ghia P; Stamatopoulos K; Sutton L-A; Rosenquist R
Article: LEUKEMIA. 2024;38(6):1287-1298
IκBε deficiency accelerates disease development in chronic lymphocytic leukemia
Bordini J; Lenzi C; Frenquelli M; Morabito A; Pseftogas A; Belloni D; Mansouri L; Tsiolas G; Perotta E; Ranghetti P; Gandini F; Genova F; Hagerstrand D; Gavriilidis G; Keisaris S; Pechlivanis N; Davi F; Kay NE; Langerak AW; Pospisilova S; Scarfo L; Makris A; Psomopoulos FE; Stamatopoulos K; Rosenquist R; Campanella A; Ghia P
Journal article: HEMASPHERE. 2022;6(Suppl):1167-1168
P1282: DISEASE‐SPECIFIC U1 SPLICEOSOMAL RNA MUTATIONS IN MATURE B‐CELL NEOPLASMS
Nadeu F; Shuai S; Clot G; Hilton LK; Diaz‐Navarro A; Martín S; Royo R; Baumann T; Kulis M; López‐Oreja I; Cossio M; Lu J; Ljungström V; Young E; Plevova K; Knisbacher BA; Lin Z; Hahn CK; Bousquets P; Alcoceba M; González M; Colado E; Aymerich M; Terol MJ; Rivas‐Delgado A; Enjuanes A; Ruiz‐Gaspà S; Chatzikonstantinou T; Hägerstrand D; Jylhä C; Skaftason A; Mansouri L; Stranska K; Doubek M; van Gastel‐Mol EJ; Davis Z; Walewska R; Scarfò L; Trentin L; Visentin A; Parikh SA; Rabe KG; Moia R; Armand M; Rossi D; Davi F; Gaidano G; Kay NE; Shanafelt T; Ghia P; Oscier D; Langerak AW; Beà S; López‐Guillermo A; Neuberg D; Wu CJ; Getz G; Pospisilova S; Stamatopoulos K; Rosenquist R; Huber W; Zenz T; Colomer D; Martín‐Subero JI; Delgado J; Morin RD; Stein LD; Puente XS; Campo E
Article: SCIENTIFIC REPORTS. 2022;12(1):9838
Altered cytoskeletal status in the transition from proneural to mesenchymal glioblastoma subtypes
Keller M; Blom M; Conze LL; Guo M; Hagerstrand D; Aspenstrom P
Article: CANCER REPORTS. 2022;5(5):e1498
The association between Annexin A2 and epithelial cell adhesion molecule in breast cancer cells
Al-Qahtani SM; Gadalla SE; Guo M; Ericsson C; Hagerstrand D; Nister M
Article: ONCOGENE. 2021;40(32):5066-5080
SFRP2 induces a mesenchymal subtype transition by suppression of SOX2 in glioblastoma
Guo M; Goudarzi KM; Abedi S; Pieber M; Sjoberg E; Behnan J; Zhang X-M; Harris RA; Bartek J; Lindstrom MS; Nister M; Hagerstrand D
Article: GLIA. 2020;68(2):316-327
Astrocytes enhance glioblastoma growth
Mega A; Nilsen MH; Leiss LW; Tobin NP; Miletic H; Sleire L; Strell C; Nelander S; Krona C; Hagerstrand D; Enger PO; Nister M; Ostman A
Article: NEURO-ONCOLOGY ADVANCES. 2020;2(1):vdaa061
Identification of functionally distinct and interacting cancer cell subpopulations from glioblastoma with intratumoral genetic heterogeneity
Guo M; van Vliet M; Zhao J; de Stahl TD; Lindstrom MS; Cheng H; Heller S; Nister M; Hagerstrand D
Article: CLINICAL CANCER RESEARCH. 2019;25(12):3702-3717
A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer
Sjoberg E; Meyrath M; Milde L; Herrera M; Lovrot J; Hagerstrand D; Frings O; Bartish M; Rolny C; Sonnhammer E; Andy CE; Augsten M; Ostman A
Journal article: NEURO-ONCOLOGY. 2018;20(suppl_6):vi263-vi264
TMIC-35. ASTROCYTE-DEPENDENT ENHANCEMENT OF GLIOBLASTOMA GROWTH AS A CANDIDATE THERAPEUTIC TARGET
Mega A; Leiss L; Nilsen MH; Tobin N; Sleire L; Strell C; Liu J; Nekhotiaeva N; Eriksson A; Nelander S; Uhrbom L; Krona C; Hägerstrand D; Enger PØ; Nistér M; Östman A
Article: CANCER RESEARCH. 2018;78(20):5901-5916
Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype
Goudarzi KM; Espinoza JA; Guo M; Bartek J; Nister M; Lindstrom MS; Hagerstrand D
Journal article: ESMO OPEN. 2018;3(Suppl 2):a359-A360
PO-336 Identification of SOX2 and SFRP2 as opposing regulators of glioblastoma heterogeneous subtypes
Guo M; Nister M; Hagerstrand D
Journal article: NEURO-ONCOLOGY. 2017;19(suppl_6):vi248
TMIC-24. ASTROCYTE-DEPENDENT ENHANCEMENT OF GLIOBLASTOMA GROWTH AS A CANDIDATE THERAPEUTIC TARGET
Mega A; Nilsen MH; Leiss LW; Sleire L; Liu J; Nelander S; Uhrbom L; Krona C; Hägerstrand D; Enger PØ; Nistér M; Östman A
Article: ONCOTARGET. 2017;8(49):84671-84684
Glioblastoma and glioblastoma stem cells are dependent on functional MTH1
Pudelko L; Rouhi P; Sanjiv K; Gad H; Kalderen C; Hoglund A; Squatrito M; Schuhmacher AJ; Edwards S; Hagerstrand D; Berglund UW; Helleday T; Brautigam L
Article: ONCOTARGET. 2016;7(45):72431-72442
PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status
Roodakker KR; Elsir T; Edqvist P-HD; Hagerstrand D; Carison J; Lysiak M; Henriksson R; Ponten F; Rosell J; Soderkvist P; Stupp R; Tchougounova E; Nister M; Malmstrom A; Smits A
Article: ONCOGENE. 2015;34(2):209-216
TRAF2 is an NF-κB-activating oncogene in epithelial cancers
Shen RR; Zhou AY; Kim E; O'Connell JT; Hagerstrand D; Beroukhim R; Hahn WC
Article: CANCER DISCOVERY. 2013;3(9):1044-1057
Systematic Interrogation of 3q26 Identifies TLOC1 and SKIL as Cancer Drivers
Hagerstrand D; Tong A; Schumacher SE; Ilic N; Shen RR; Cheung HW; Vazquez F; Shrestha Y; Kim SY; Giacomelli AO; Rosenbluh J; Schinzel AC; Spardy NA; Barbie DA; Mermel CH; Weir BA; Garraway LA; Tamayo P; Mesirov JP; Beroukhim R; Hahn WC
Article: NEURO-ONCOLOGY. 2011;13(11):1178-1191
Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile
Hagerstrand D; He X; Lindh MB; Hoefs S; Hesselager G; Ostman A; Nister M
Article: ANTI-CANCER DRUGS. 2010;21(8):759-765
Chimeric tyrosine kinase-HDAC inhibitors as antiproliferative agents
Uecker A; Sicker M; Beckers T; Mahboobi S; Hagerstrand D; Ostman A; Bohmer F-D
Article: NEURO-ONCOLOGY. 2010;12(9):967-975
PI3K/PTEN/Akt pathway status affects the sensitivity of high-grade glioma cell cultures to the insulin-like growth factor-1 receptor inhibitor NVP-AEW541
Hagerstrand D; Lindh MB; Pena C; Garcia-Echeverria C; Nister M; Hofmann F; Ostman A
Article: NEURO-ONCOLOGY. 2008;10(1):2-9
Gene expression analyses of grade II gliomas and identification of rPTPβ/ζ as a candidate oligodendroglioma marker
Haegerstrand D; Smits A; Eriksson A; Sigurclarclottir S; Olofsson T; Hartman M; Nister M; Kalimo H; Oetman A
Article: ONCOGENE. 2006;25(35):4913-4922
Characterization of an imatinib-sensitive subset of high-grade human glioma cultures
Hagerstrand D; Hesselager G; Achterberg S; Bolin UW; Kowanetz M; Kastemar M; Heldin C-H; Isaksson A; Nister M; Ostman A
Journal article: EUROPEAN JOURNAL OF CANCER, SUPPLEMENT. 2004;2(8):30
89 Gene expression profiling of cancer associated fibroblasts
Micke P; Sundquist C; Hägerstrand D; Scheidl S; Lindahl P; Pontén F; Heldin CH; Ostman A
Journal article: EUROPEAN JOURNAL OF CANCER, SUPPLEMENT. 2004;2(8):109
363 Targeting of PDGF receptors; combination effects in various solid tumors and identification of a PDGF dependent brain tumor subset
Östman A; Hägerstrand D; Pietras K; Furuhashi M; Wu Y; Hicklin DJ; Buchdunger E; Abe M; Nister M; Baranowska-Kortylewicz J; Heldin C-H
Visa fler

Alla övriga publikationer

Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Supplementary Data from A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer
Sjöberg E; Meyrath M; Milde L; Herrera M; Lövrot J; Hägerstrand D; Frings O; Bartish M; Rolny C; Sonnhammer E; Chevigné A; Augsten M; Östman A
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Figure S1 from Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype
Goudarzi KM; Espinoza JA; Guo M; Bartek J; Nistér M; Lindström MS; Hägerstrand D
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Figure S3 from Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype
Goudarzi KM; Espinoza JA; Guo M; Bartek J; Nistér M; Lindström MS; Hägerstrand D
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Table S3 from Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype
Goudarzi KM; Espinoza JA; Guo M; Bartek J; Nistér M; Lindström MS; Hägerstrand D
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Supplementary Data from A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer
Sjöberg E; Meyrath M; Milde L; Herrera M; Lövrot J; Hägerstrand D; Frings O; Bartish M; Rolny C; Sonnhammer E; Chevigné A; Augsten M; Östman A
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Data from Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype
Goudarzi KM; Espinoza JA; Guo M; Bartek J; Nistér M; Lindström MS; Hägerstrand D
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Data from Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype
Goudarzi KM; Espinoza JA; Guo M; Bartek J; Nistér M; Lindström MS; Hägerstrand D
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Table S1 from Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype
Goudarzi KM; Espinoza JA; Guo M; Bartek J; Nistér M; Lindström MS; Hägerstrand D
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Figure S2 from Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype
Goudarzi KM; Espinoza JA; Guo M; Bartek J; Nistér M; Lindström MS; Hägerstrand D
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Data from A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer
Sjöberg E; Meyrath M; Milde L; Herrera M; Lövrot J; Hägerstrand D; Frings O; Bartish M; Rolny C; Sonnhammer E; Chevigné A; Augsten M; Östman A
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Table S4 from Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype
Goudarzi KM; Espinoza JA; Guo M; Bartek J; Nistér M; Lindström MS; Hägerstrand D
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Table S3 from Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype
Goudarzi KM; Espinoza JA; Guo M; Bartek J; Nistér M; Lindström MS; Hägerstrand D
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Table S1 from Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype
Goudarzi KM; Espinoza JA; Guo M; Bartek J; Nistér M; Lindström MS; Hägerstrand D
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Table S4 from Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype
Goudarzi KM; Espinoza JA; Guo M; Bartek J; Nistér M; Lindström MS; Hägerstrand D
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Supplementary Figure Legends from A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer
Sjöberg E; Meyrath M; Milde L; Herrera M; Lövrot J; Hägerstrand D; Frings O; Bartish M; Rolny C; Sonnhammer E; Chevigné A; Augsten M; Östman A
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Table S2 from Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype
Goudarzi KM; Espinoza JA; Guo M; Bartek J; Nistér M; Lindström MS; Hägerstrand D
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Table S2 from Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype
Goudarzi KM; Espinoza JA; Guo M; Bartek J; Nistér M; Lindström MS; Hägerstrand D
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Figure S2 from Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype
Goudarzi KM; Espinoza JA; Guo M; Bartek J; Nistér M; Lindström MS; Hägerstrand D
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Figure S1 from Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype
Goudarzi KM; Espinoza JA; Guo M; Bartek J; Nistér M; Lindström MS; Hägerstrand D
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Figure S3 from Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype
Goudarzi KM; Espinoza JA; Guo M; Bartek J; Nistér M; Lindström MS; Hägerstrand D
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Supplementary Figure Legends from A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer
Sjöberg E; Meyrath M; Milde L; Herrera M; Lövrot J; Hägerstrand D; Frings O; Bartish M; Rolny C; Sonnhammer E; Chevigné A; Augsten M; Östman A
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Data from A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer
Sjöberg E; Meyrath M; Milde L; Herrera M; Lövrot J; Hägerstrand D; Frings O; Bartish M; Rolny C; Sonnhammer E; Chevigné A; Augsten M; Östman A
Corrigendum: ONCOGENE. 2021;40(32):5153
SFRP2 induces a mesenchymal subtype transition by suppression of SOX2 in glioblastoma (May, 10.1038/s41388-021-01825-2, 2021)
Guo M; Goudarzi KM; Abedi S; Pieber M; Sjoberg E; Behnan J; Zhang X-M; Harris RA; Bartek J; Lindstrom MS; Nister M; Hagerstrand D
Corrigendum: ONCOTARGET. 2020;11(8):827
Correction: Glioblastoma and glioblastoma stem cells are dependent on functional MTH1.
Pudelko L; Rouhi P; Sanjiv K; Gad H; Kalderén C; Höglund A; Squatrito M; Schuhmacher AJ; Edwards S; Hägerstrand D; Berglund UW; Helleday T; Bräutigam L
Conference publication: NEURO-ONCOLOGY. 2018;20:263-264
ASTROCYTE-DEPENDENT ENHANCEMENT OF GLIOBLASTOMA GROWTH AS A CANDIDATE THERAPEUTIC TARGET
Mega A; Leiss L; Nilsen MH; Tobin N; Sleire L; Strell C; Liu J; Nekhotiaeva N; Eriksson A; Nelander S; Uhrbom L; Krona C; Hagerstrand D; Enger PO; Nister M; Ostman A
Conference publication: NEURO-ONCOLOGY. 2017;19:248
ASTROCYTE-DEPENDENT ENHANCEMENT OF GLIOBLASTOMA GROWTH AS A CANDIDATE THERAPEUTIC TARGET
Mega A; Nilsen MH; Leiss LW; Sleire L; Liu J; Nelander S; Uhrbom L; Krona C; Hagerstrand D; Enger PO; Nister M; Ostman A
Meeting abstract: CANCER RESEARCH. 2016;76:2385
Understanding the dynamic interplay between genetically different cancer cell clones in glioblastoma
Guo M; Heller S; Thorslund J; Orre L; Lehtio J; Nister M; Hagerstrand D
Meeting abstract: NEURO-ONCOLOGY. 2014;16:v122-v123
PRO-MIGRATORY AND -PROLIFERATIVE EFFECTS OF ASTROCYTES ON GBM CELLS
Mega A; Sleire L; Hagerstrand D; Enger PO; Nister M; Ostman A
Thesis / dissertation: 2007
Molecular determinants of glioma subsets with distinct histology or sensitivity to signal transduction inhibitors
Hägerstrand, Daniel
Conference publication: ANNALS OF ONCOLOGY. 2007;18:45
Analyses of roles of gene expression and PTEN-PI3K-AKT pathway in determination of sensitivity to the IGF-1 receptor inhibitor NVP-AEW541 in high grade glioma cell cultures
Hagerstrand D; Bradic M; Garcia-Echeverria C; Nister M; Hofmann F; Ostman A
Conference publication: ANNALS OF ONCOLOGY. 2005;16:21
PDGF receptors as cancer drug targets
Ostman A; Pietras K; Hägerstrand D; Furuhashi M; Abe M; Robinson S; Wu Y; Hicklin DJ; Baranowska-Kortylewicz J; Nister M; Heldin CH; Rubin K
Conference publication: ANNALS OF ONCOLOGY. 2005;16:43
Characterization of the sensitivity of high grade glioma cultures to inhibitors of PDGF- and IGF1-receptors
Bradic M; Hägerstrand D
Visa fler

Anställningar

Senior Forskningsspecialist, Molekylär medicin och kirurgi, Karolinska Institutet, 2022-

Examina och utbildning

MEDICINE DOKTORSEXAMEN, Institutionen för onkologi-patologi, Karolinska Institutet, 2007

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI